Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
about
Effects of carvedilol on cardiac autonomic nerve activities during sinus rhythm and atrial fibrillation in ambulatory dogs.Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importanceAlpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.Adrenergic signaling in heart failure: a balance of toxic and protective effects.Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.Long-term oral carvedilol in chronic heart failure.Improvement in heart rate turbulence as a measure of response to beta-blocker therapy for heart failure.Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study.Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock.Klinischer Einsatz von Beta-Blockern bei kardiovaskulären Indikationen: Neue Therapiestudien
P2860
Q33845188-9EEB3600-BBD1-491E-8F4C-A90F8D59F388Q34892203-3146D762-0919-48A6-BF50-3008CE77BE25Q35862163-DAD94CF0-FAB8-4F09-A25F-D5E55A9DBFF0Q37327391-E599ABF7-F5F8-43C8-886F-92EBECAF3192Q37432103-B77E6746-5AFE-43AA-BDF1-64979D0BB8C9Q37692816-E5D4286B-C5BC-4C3C-8BC0-9BEBC9E80E01Q38195518-AC620F74-83C6-4AD8-9FB6-07DC9236BDD8Q38944593-BD00CF19-BEF9-40A1-A93C-7CF2F0E91B2BQ38951165-525A6933-EDC2-46CE-8407-BCAAB0F7E3FCQ44910691-0CD60693-F43B-4866-B5AA-30D7B00A1713Q44976041-BF090DDD-EFC3-44B9-8F4A-67B3D12CE5C6Q45917636-2A65B873-0E47-4D6B-8388-C3CC2A6D5B5AQ46616032-ECBBEE55-9036-4DD3-A474-1AB05A9E6F16Q46724107-6FCB5C48-026C-4A8F-9F13-C949BA643DFBQ46743813-2993C054-9A11-49A3-AE08-1B7436DAD111Q51033989-A03243F7-14D7-4972-87A1-5D226EE4CAF7Q56624513-CFF1B187-39AA-4391-82B1-F7561A25CED3
P2860
Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Selective versus nonselective ...... learned from the COMET trial?
@ast
Selective versus nonselective ...... learned from the COMET trial?
@en
type
label
Selective versus nonselective ...... learned from the COMET trial?
@ast
Selective versus nonselective ...... learned from the COMET trial?
@en
prefLabel
Selective versus nonselective ...... learned from the COMET trial?
@ast
Selective versus nonselective ...... learned from the COMET trial?
@en
P2093
P1476
Selective versus nonselective ...... learned from the COMET trial?
@en
P2093
Arthur M Feldman
Kirkwood F Adams
Michael R Bristow
Sidney Goldstein
P304
P356
10.1016/J.CARDFAIL.2003.10.009
P577
2003-12-01T00:00:00Z